Académique Documents
Professionnel Documents
Culture Documents
• PATHOGENESIS
• LIFE CYCLES
• EMERGING VIRUSES
• VACCINE DEVELOPMENT
• DRUG RESISTANCE
1
VIRAL GENETICS
2
VIRAL GENETICS
• VIRUSES GROW RAPIDLY
• A SINGLE PARTICLE PRODUCES A LOT
OF PROGENY
• DNA VIRUSES SEEM TO HAVE ACCESS
TO PROOF READING, RNA VIRUSES DO
NOT
3
NATURE OF GENOMES
• RNA or DNA
• SEGMENTED OR NON-SEGMENTED
4
GENETIC CHANGE
• MUTATION
• RECOMBINATION
5
ORIGIN OF MUTATIONS
• SPONTANEOUS
– tautomeric form of bases
– polymerase errors
6
Tautomeric forms of bases
7
ORIGIN OF MUTATIONS
• SPONTANEOUS
– tautomeric form of bases
– polymerase errors
mutation rates usually higher in RNA viruses (lack of proof
reading)
8
ORIGIN OF MUTATIONS
• SPONTANEOUS
• PHYSICALLY INDUCED
–UV light , especially problem if no
access to repair
–X-rays
• CHEMICALLY INDUCED
9
TYPES OF MUTATION
• POINT
•INSERTION
•DELETION
10
PHENOTYPES
PHENOTYPE
11
PHENOTYPIC CHANGES
• CONDITIONAL LETHAL - multiply under
some conditions but not others - wild-type
(wt) grows under both sets of conditions
13
PHENOTYPIC CHANGES
• “HOT MUTANTS”
– grow better at elevated temperature than wt
– less susceptible to fever
• ATTENUATED MUTANTS
– milder (or no) symptoms
– vaccine development
– pathogenesis
14
GENETIC CHANGE
• MUTATION
• RECOMBINATION
15
RECOMBINATION
16
RECOMBINATION
‘classic’ recombination common in DNA viruses
17
COPY CHOICE
RECOMBINATION
18
COPY CHOICE
RECOMBINATION
19
COPY CHOICE
RECOMBINATION
20
COPY CHOICE
RECOMBINATION
21
RECOMBINATION - SOME USES
22
RECOMBINATION - SOME USES
marker rescue
23
RECOMBINATION - SOME USES
• mapping by recombination frequency
• mapping by marker rescue
• development of recombinant viruses for
vaccines and therapeutic reasons
24
RECOMBINATION - SOME USES
25
REASSORTMENT
26
REASSORTMENT
• form of recombination (non classical)
• very efficient
• segmented viruses only
• used in some new vaccines
27
adapted from
Treanor JJ Infect. Med. 15:714
28
NON-SEGMENTED NEGATIVE
STRAND RNA VIRUSES
• no classical recombination
• no copy choice
• no reassortment
29
COMPLEMENTATION
Interaction at the functional level, NOT the nucleic
acid level
31
DEFECTIVE VIRUSES
32
DEFECTIVE INTERFERING (DI)
VIRUSES (PARTICLES)
• decrease replication of helper virus
– compete for viral precursors, etc.
no changes in genome
possibly altered host range
possibly resistant to antibody neutralization
34
PHENOTYPIC MIXING
35